Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

M.A. Sanz, P. Montesinos, C. Rayon, A. Holowiecka, J. de la Serna, G. Milone, E. de Lisa, S. Brunet, V. Rubio, J.M. Ribera, C Rivas, I. Krsnik, J. Bergua, J. Gonzalez, J. Diaz-Mediavilla, R. Rojas, F. Manso, G.J. Ossenkoppele, J.D. Gonzalez, B. LowenbergG. Pethema, G. Hovon

Research output: Contribution to journalArticleAcademicpeer-review

258 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)5137-5146
JournalBlood
Volume115
Issue number25
DOIs
Publication statusPublished - 2010

Cite this